Navigation Links
Concord Coalition Says New Trustees' Report Demonstrates the Importance of Health Care Cost Control
Date:5/12/2009

WASHINGTON, May 12 /PRNewswire-USNewswire/ -- With today's release of the annual Social Security and Medicare Trustees' Reports again showing that the nation's two largest programs are on a troubled fiscal path, The Concord Coalition urged politicians to work together on reforms of both programs aimed at producing a sustainable future. Reform efforts will need to recognize the underlying structural factors contributing to their unsustainability -- demographic changes and escalating health care costs.

"Today's report documents a failure of generational stewardship. We should not be content that Social Security and Medicare are affordable for today's beneficiaries when they are not sustainable for future generations. This is particularly relevant now, when health care reform is high on the political agenda. Today's report is a timely reminder that cost control must be a vital part of any reform plan that Congress takes up this year. It is a matter of arithmetic, not ideology. Absent reform, Medicare costs will skyrocket far beyond what can be reasonably paid for and the longer we delay in making hard choices the more dire the situation will become," said Robert L. Bixby, Executive Director of The Concord Coalition.

Despite the attention focused on when the Social Security and Medicare Part A trust funds become "insolvent," The Concord Coalition again warned that trust fund solvency is a poor indicator of the fiscal outlook for these programs.

"For too long, efforts to reform these programs have been minimized by references to trust-fund accounting. Use of this indicator not only misleads the public about the timing and magnitude of the looming fiscal burden, but it says nothing about these programs' impact on national savings and generational equity. The trust funds are an accounting device for keeping track of the programs' claims on general revenues. Their existence does not, therefore, ease the burden of pa
'/>"/>

SOURCE The Concord Coalition
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. United Concordia Reminds Parents to Protect Childrens Teeth During Halloween & Year-Round
2. United Concordia Unveils New Online Capabilities for Producers
3. United Concordia Celebrates National Childrens Dental Health Month
4. Davis Vision, United Concordia Free Clinic Promotes Childrens Eye and Dental Health
5. United Concordia Launches New Online Dental Health Center
6. United Concordia Dental Celebrates National Smile Month
7. Drinking polyphenol-rich Concord grape juice may improve memory in older adults
8. Highmark Blue Cross Blue Shield, United Concordia and Catholic Charities Join Forces to Offer Free Health, Dental Services This Saturday
9. Staying Sharp in Concord, NC
10. National Dental Insurer United Concordia to Receive $660 Million Contract From U.S. Department of Defense
11. VivoMetrics LifeShirt(R) Selected by Concordia University to Provide Patient Data for Healthy Heart Research Project
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 1Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 2FRCs Tony Perkins Commends Pro life Lawmakers Who Oppose Federal Funding of Abortion 51676 1FRCs Tony Perkins Commends Pro life Lawmakers Who Oppose Federal Funding of Abortion 51676 2Sono Tek Announces First Quarter Results 51672 1Sono Tek Announces First Quarter Results 51672 2Sono Tek Announces First Quarter Results 51672 3